Acute tryptophan depletion. Part I: Rationale and methodology

Australian and New Zealand Journal of Psychiatry

Volumn 39, Issue 7, 2005, Pages 558-564

  Hood, Sean D ^b   Bell, Caroline J ^c   Nutt, David J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Methodology; Psychopharmacology; Serotonin; Tryptophan

Indexed keywords

SEROTONIN; TRYPTOPHAN;

ANXIETY DISORDER; DEPRESSION; DIET; EXPERIMENTATION; HUMAN; MEDICAL RESEARCH; METHODOLOGY; NEUROENDOCRINOLOGY; NEUROIMAGING; REVIEW;

BLOOD-BRAIN BARRIER; HUMANS; MENTAL DISORDERS; SEROTONIN; TRYPTOPHAN;

EID: 27744486264     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1614.2005.01627.x     Document Type: Review

References (61)

1. Rose WC, Haines WJ, Warner DT. The amino acid requirement of man. Journal of Biological Chemistry 1950; 206:421-430.
2. McMenamy RH. Binding of indole analogues to human serum albumin. Effects of fatty acids. Journal of Biological Chemistry 1965; 240:4235-4243.
3. Tagliamonte A, Biggio G, Vargiu L, Gessa GL. Free tryptophan in serum controls brain tryptophan level and serotonin synthesis. Life Sciences. Part 2. Biochemistry, General and Molecular Biology 1973; 12:277-287.
4. Oldendorf WH, Szabo J. Amino acid assignment to one of three blood-brain barrier amino acid carriers. American Journal of Physiology 1976; 230:94-98.
5. Fernstrom JD. Diet-induced changes in plasma amino acid pattern: effects on the brain uptake of large neutral amino acids, and on brain serotonin synthesis. Journal of Neural Transmission. Supplementum 1979:55-67.
6. Wurtman RJ, Wurtman JJ, Regan MM, McDermott JM, Tsay RH, Breu JJ. Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios. American Journal of Clinical Nutrition 2003; 77:128-132.
7. Schaechter JD, Wurtman RJ. Serotonin release varies with brain tryptophan levels. Brain Research 1990; 532:203-210.
8. Engelman K, Lovenberg W, Sjoerdsma A. Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome. New England Journal of Medicine 1967; 277:1103-1108.
9. Shopsin B, Gershon S, Goldstein M, Friedman E, Wilk S. Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Psychopharmacology Communications 1975; 1:239-249.
10. Shopsin B, Friedman E, Gershon S. Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients. Archives of General Psychiatry 1976; 33:811-819.
11. Miller HL, Delgado PL, Salomon RM, Licinio J, Barr LC, Charney DS. Acute tryptophan depletion: a method of studying antidepressant action. Journal of Clinical Psychiatry 1992; 53:28-35.
12. Lanoir J, Ternaux JP, Pons C, Lagarde JM. Long-term effects of a tryptophan-free diet on serotonin metabolism and sleep-waking balance in rats. Experimental Brain Research 1981; 41: 346-357.
13. Moja EA, Mendelson WB, Stoff DM, Gillin JC, Wyatt RJ. Reduction of REM sleep by a tryptophan-free amino acid diet. Life Sciences 1979; 24:1467-1470.
14. Delgado PL, Charney DS, Price LH, Landis H, Heninger GR. Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. Life Sciences 1989; 45:2323-2332.
15. Anderson IM, Parry-Billings M, Newsholme EA, Fairburn CG, Cowen PJ. Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychological Medicine 1990; 20:785-791.
16. Gartside SE, Cowen PJ, Sharp T. Evidence that the large neutral amino acid L-valine decreases electrically-evoked release of 5-HT in rat hippocampus in vivo. Psychopharmacologia 1992; 109:251-253.
17. Williamson DJ, McTavish SF, Park SB, Cowen PJ. Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients. British Journal of Psychiatry 1995; 167:238-242.
18. Reilly JG, McTavish SFB, Young AH. Rapid depletion of plasma tryptophan: a review of studies and experimental methodology. Journal of Psychopharmacology 1997; 11:381-392.
19. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Archives of General Psychiatry 1990; 47:411-418.
20. Young SN, Smith SE, Pihl RO, Ervin FR. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 1985; 87:173-177.
21. Lieben CKJ, Oorsouw KV, Deutz NEP, Blokland A. Acute tryptophan depletion induced by a gelatin-based mixture impairs object memory but not affective behavior and spatial learning in the rat. Behavioural Brain Research 2004; 151:53-64.
22. Lieben CKJ, Blokland A, Westerink B, Deutz NEP. Acute tryptophan and serotonin depletion using an optimized tryptophan-free protein-carbohydrate mixture in the adult rat. Neurochemistry International 2004; 44:9-16.
23. Van der Does AJW. The effects of tryptophan depletion on mood and psychiatric symptoms. Journal of Affective Disorders 2001; 64:107-119.
24. Moore P, Landolt HP, Seifritz E et al. Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology 2000; 23:601-622.
25. Weltzin TE, Fernstrom JD, McConaha C, Kaye WH. Acute tryptophan depletion in bulimia: effects on large neutral amino acids. Biological Psychiatry 1994; 35:388-397.
26. Krahn LE, Lu PY, Klee G, Delgado PR, Lin SC, Zimmermann RC. Examining serotonin function: a modified technique for rapid tryptophan depletion. Neuropsychopharmacology 1996; 15:325-328.
27. Booji L, Van der Does W, Haffmans PMJ, Spinhoven P, McNally RJ. Acute tryptophan depletion as a model of depressive relapse: behavioural specificity and ethical considerations. British Journal of Psychiatry (in press).
28. Booji L, Van der Does W, Haffmans PMJ, Riedel WJ, Fekkes D, Blom MJB. The effects of high-dose and low-dose tryptophan depletion on mood and cognitive functions of remitted depressed patients. Journal of Psychopharmacology 2005; 19:267-275.
29. Spillmann MK, Van der Does AJW, Rankin MA et al. Tryptophan depletion in SSRI-recovered depressed outpatients. Psychopharmacology 2001; 155:123-127.
30. Hayward G, Goodwin GM, Cowen PJ, Harmer CJ. Low does tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symtpoms. Biological Psychiatry 2005; 57:517-524.
31. Booij L, Van der Does AJ, Riedel WJ. Monoamine depletion in psychiatric and healthy populations: review. Molecular Psychiatry 2003; 8:951-973.
32. Van der Does AJ. The mood-lowering effect of tryptophan depletion: possible explanation for discrepant findings. Archives of General Psychiatry 2001; 58:200-202.
33. Nishizawa S, Benkelfat C, Young SN et al. Differences between males and females in rates of serotonin synthesis in human brain. Proceedings of the National Academy of Sciences of the United States of America 1997; 94:5308-5313.
34. Smith KA, Clifford EM, Hockney RA, Clark DM, Cowen PJ. Effect of tryptophan depletion on mood in male and female volunteers: a pilot study. Human Psychopharmacology 1997; 12:111-117.
35. Carpenter LL, Anderson GM, Pelton GH et al. Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 1998; 19:26-35.
36. Williams WA, Shoaf SE, Hommer D, Rawlings R, Linnoila M. Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. Journal of Neurochemistry 1999; 72:1641-1647.
37. Young SN, Ervin FR, Pihl RO, Finn P. Biochemical aspects of tryptophan depletion in primates. Psychopharmacology 1989; 98:508-511.
38. Biggio G, Fadda F, Fanni P, Tagliamonte A, Gessa GL. Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free diet. Life Sciences 1974; 14:1321-1329.
39. Gessa GL, Biggio G, Fadda F, Corsini GU, Tagliamonte A. Effect of the oral administration of tryptophan-free amino acid mixtures on serum tryptophan, brain tryptophan and serotonin metabolism. Journal of Neurochemistry 1974; 22:869-870.
40. Moja EA, Cipolla P, Castoldi D, Tofanetti O. Dose-response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats. Life Sciences 1989; 44:971-976.
41. Stancampiano R, Melis F, Sarais L, Cocco S, Cugusi C, Fadda F. Acute administration of a tryptophan-free amino acid mixture decreases 5-HT release in rat hippocampus in vivo. American Journal of Physiology 1997; 272:R991-R994.
42. Sharp T, Bramwell SR, Grahame-Smith DG. Effect of acute administration of L-tryptophan on the release of 5-HT in rat hippocampus in relation to serotoninergic neuronal activity: an in vivo microdialysis study. Life Sciences 1992; 50:1215-1223.
43. Bel N, Artigas F. Reduction of serotonergic function in rat brain by tryptophan depletion: effects in control and fluvoxamine-treated rats. Journal of Neurochemistry 1996; 67:669-676.
44. Bremner JD, Innis RB, Salomon RM et al. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Archives of General Psychiatry 1997; 54:364-374.
45. Smith KA, Morris JS, Friston KJ, Cowen PJ, Dolan RJ. Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. British Journal of Psychiatry 1999; 174:525-529.
46. Neumeister A, Nugent AC, Waldeck T et al. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Archives of General Psychiatry 2004; 61:765-773.
47. Drevets WC. Neuroimaging studies of mood disorders. Biological Psychiatry 2000; 48:813-829.
48. Yatham LN, Liddle PF, Shiah IS et al. Effects of rapid tryptophan depletion on brain 5-HT2 receptors: a PET study. British Journal of Psychiatry 2001; 178:448-453.
49. Coccaro EF, Kavoussi RJ, Cooper TB, Hauger R. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects. Psychopharnmcology 1998; 138:9-15.
50. 1A receptor. Psychopharmacology 2000; 147:439-441.
51. Price LH, Malison RT, McDougle CJ, McCance-Katz EF, Owen KR, Heninger GR. Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP). Neuropsychopharnmcology 1997; 17:342-350.
52. Price LH, Malison RT, McDougle CJ, Pelton GH, Heninger GR. The neurobiology of tryptophan depletion in depression: effects of intravenous tryptophan infusion. Biological Psychiatry 1998; 43:339-347.
53. Smith KA, Williams C, Cowen PJ. Impaired regulation of brain serotonin function during dieting in women recovered from depression. British Journal of Psychiatry 2000; 176:72-75.
54. Cowen PJ, Clifford EM, Walsh AE, Williams C, Fairburn CG. Moderate dieting causes 5-HT2C receptor supersensitivity. Psychological Medicine 1996; 26:1155-1159.
55. Walsh AE, Oldman AD, Franklin M, Fairburn CG, Cowen PJ. Dieting decreases plasma tryptophan and increases the prolactin response to d-fenfluramine in women but not men. Journal of Affective Disorders 1995; 33:89-97.
56. Franklin M, Craven RD, Dowling B, Campling G, Elliott JM, Cowen PJ. Effect of a long-term low tryptophan diet on the prolactin responses to the 5-HTiA and 5-HT2C agonists, 8-OH-DPAT and mCPP in the male rat. Journal of Psychopharmacology 1999; 13:58-63.
57. Golightly KL, Lloyd JA, Hobson JE, Gallagher P, Mercer G, Young AH. Acute tryptophan depletion in schizophrenia. Psychological Medicine 2001; 31:75-84.
58. Hughes JH, Gallagher P, Young AH. Effects of acute tryptophan depletion on cognitive function in euthymic bipolar patients. European Neuropsychopharmacology 2002; 12:123-128.
59. Klaassen T, Riedel WJ, Deutz NE, van Someren A, van Praag HM. Specificity of the tryptophan depletion method. Psychopharmacology 1999; 141:279-286.
60. Charney DS. Drug discovery for major psychiatric disorders: Unipolar. In: 16th European College of Neurospychopharmacology Congress; October 2003, Prague, Czech Republic.
61. Psychopathology of tryptophan (Symposium). International Congress of Biological Psychiatry; March 2004, Sydney, Australia.